Market›Health Care›Biotechnology›Biotechnology
SHUTTLE PHARMACEUTIC

SHPH

$1.03Aug 31, 2022 – Apr 24, 2026
Health CareBiotechnology$4M
MVM
-$0.2M
TD Variance
-1.078

Every news event mapped to its market reaction — 150 events, 44 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2022-09-06+142.9%newsSeeking AlphaNewly public Shuttle Pharmaceuticals shares rally 70% after plunging in prior session
2022-09-06+142.9%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2022-12-02+107.4%newsSeeking AlphaRadiation therapy drug maker Shuttle Pharmaceuticals stock rockets 71%
2022-09-15-73.7%newsSeeking AlphaShuttle Pharma awarded new patents for its radiation sensitizing technology platform
2022-09-02-44.2%newsSeeking AlphaShuttle Pharmaceuticals stock plunges 75% after rallying 545% since $10M IPO
2025-06-12-39.6%newsSeeking AlphaShuttle Pharmaceuticals announces 25-for-1 reverse stock split; shares down over 26%
2026-03-27-35.8%earningsTMX NewsfileRETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
2026-03-27-35.8%newsBenzinga12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
2022-09-20-30.5%expansionSeeking AlphaShuttle stock falls 10% amid manufacturing contract for ropidoxuridine with TCG
2022-09-20-30.5%newsmarketscreener.comSHUTTLE PHARMACEUTICALS HOLDINGS, INC. - marketscreener.com
2024-09-05-29.3%newsChartMillThe trading volume of these stocks is deviating from the norm in today's session. - ChartMill
2023-01-12+28.5%newsSeeking AlphaShuttle announces private offering of $4.3M
2023-01-12+28.5%legalSEC EDGARSHPH 8-K: 1.01, 3.02, 8.01 (SEC Filing)
2022-09-09+28.0%newsSeeking AlphaShuttle Pharmaceuticals stock jumps 18%, continuing rocky post-IPO ride
2022-09-09+28.0%newsThe Motley FoolWhy Shares of Shuttle Pharmaceuticals Jumped 160.4% This Week - The Motley Fool
2025-11-21-27.6%M&ASeeking AlphaShuttle Pharmaceuticals acquires AI health platform
2025-11-21-27.6%legalSEC EDGARSHPH 8-K: 1.01, 1.02, 2.05 (SEC Filing)
2025-11-21-27.6%M&AInvesting.comShuttle Pharmaceuticals stock falls after closing Molecule.ai acquisition - Investing.com
2025-11-21-27.6%newsStocksToTradeWhy Does SHPH Stock Dip? - StocksToTrade
2025-11-21-27.6%M&ATMX NewsfileShuttle Pharmaceuticals Acquires AI Health Platform - TMX Newsfile
2025-11-21-27.6%newsInvesting.comShuttle Pharmaceuticals settles Theradex dispute and discontinues Ropidoxuridine trials - Investing.com
2026-01-20+26.1%newsStocksToTradeShuttle Pharmaceuticals’ Stock Surges Amid Strategic Developments - StocksToTrade
2026-01-20+26.1%newsChartMillLet's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
2026-01-20+26.1%newsChartMillWondering what's happening in today's pre-market session? - ChartMill
2026-01-20+26.1%earningsBenzingaDow Falls Over 500 Points; 3M Posts Upbeat Earnings - Benzinga
2026-01-20+26.1%newsInteractiveCryptoCrypto: SHPH at Critical Level: Why This Week Matters - InteractiveCrypto
2026-01-12-25.9%legalSEC EDGARSHPH 8-K: 5.02 and (SEC Filing)
2025-09-17+23.7%legalSEC EDGARSHPH 8-K: 5.02 (SEC Filing)
2025-11-28+23.6%legalSEC EDGARSHPH 8-K: 5.02 and (SEC Filing)
2026-03-26-22.5%expansionTMX NewsfileShuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
2026-03-26-22.5%newsStock TitanShuttle Pharma's new AI agent is built for multi-step drug research - Stock Titan
2026-03-26-22.5%expansionThe Globe and MailShuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows - The Globe and Mail
2024-01-08-20.7%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2025-11-29+17.2%earningsThe Globe and MailShuttle Pharmaceuticals CFO Resigns, Interim CEO Steps In - The Globe and Mail
2025-04-04+16.8%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2023-01-26-16.2%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2025-11-22-15.8%M&ASeeking AlphaKey deals this week: Kenvue, Warner Bros. Discovery, Adobe, Workday and more
2025-03-13-15.6%legalSEC EDGARSHPH 8-K: 1.01, 3.01, 7.01 (SEC Filing)
2025-01-21+15.3%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2024-09-20-15.2%newsSeeking AlphaShuttle Pharmaceuticals files for offering common stock, warrants
2024-11-01-14.6%legalSEC EDGARSHPH 8-K: 1.01, 7.01 (SEC Filing)
2026-03-06+14.4%newsTMX NewsfileShuttle Pharmaceuticals Announces $3.5 Million Public Offering
2026-03-06+14.4%newsSeeking AlphaShuttle Pharmaceuticals announces $3.5 million public offering
2026-03-06+14.4%newsTMX NewsfileShuttle Pharmaceuticals Announces $3.5 Million Public Offering - TMX Newsfile
2026-03-06+14.4%newsStock TitanAI drug discovery firm Shuttle Pharma raises $3.5M in public offering - Stock Titan
2024-08-28-13.6%newsSeeking AlphaShuttle Pharma regains compliance with Nasdaq minimum bid price requirement
2024-08-28-13.6%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2023-03-09-12.6%legalSEC EDGARSHPH 8-K: 1.01, 8.01 (SEC Filing)
2025-01-28-12.1%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2025-10-21-12.0%legalSEC EDGARSHPH 8-K: 1.01, 1.02 (SEC Filing)
2025-10-21-12.0%M&ATMX NewsfileShuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform - TMX Newsfile
2022-09-24+11.4%newsYahoo! Finance CanadaShuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price, News, Quote & History - Yahoo! Finance Canada
2025-06-13-11.1%newsYahoo FinanceShuttle Pharmaceuticals says reverse stock split to become effective June 16 - Yahoo Finance
2026-04-01+10.9%newsCổng thông tin điện tử Tỉnh Sơn LaSHPH Stock Analysis: Shuttle Pharmaceuticals Holdings Inc. trades at 0.69 with 1.66 percent gain - Cổng thông tin điện tử Tỉnh Sơn La
2023-04-06-10.8%newsCoinCodexShuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
2025-02-28-10.1%legalSEC EDGARSHPH 8-K: 1.01, 2.03, 5.02 (SEC Filing)
2023-05-26-9.7%legalSEC EDGARSHPH 8-K: 2.02, 3.01 (SEC Filing)
2026-04-21-9.4%newsMSNShuttle Pharmaceuticals announces $3.5 million public offering - MSN
2022-11-01-9.3%legalSEC EDGARSHPH 8-K: 5.02, 5.03 (SEC Filing)
2026-03-10-8.7%legalSEC EDGARSHPH 8-K: 1.01, 7.01 (SEC Filing)
2026-02-02-8.6%legalSEC EDGARSHPH 8-K: 5.02 and (SEC Filing)
2025-05-15-8.4%legalSEC EDGARSHPH 8-K: 5.02 and 5.07 (SEC Filing)
2025-05-15-8.4%newsTipRanksShuttle Pharmaceuticals Announces Leadership Changes and Meeting Outcomes - TipRanks
2025-11-07-7.5%legalSEC EDGARSHPH 8-K: 1.01, 3.02 (SEC Filing)
2023-08-15-7.3%earningsSeeking AlphaShuttle Pharmaceuticals reports Q2 results
2023-08-15-7.3%legalSEC EDGARSHPH 8-K: 2.02 and (SEC Filing)
2025-09-22+7.2%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2022-09-22-7.1%legalSEC EDGARSHPH 8-K: 1.01 (SEC Filing)
2026-01-13+7.0%newsStock TitanUtah lets AI refill meds—and how a drug discovery platform fits this shift - Stock Titan
2024-04-29+6.9%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2025-09-18-6.9%legalSEC EDGARSHPH 8-K: 5.02 (SEC Filing)
2023-03-22-6.8%legalSEC EDGARSHPH 8-K: 1.01, 4.01, 7.01, 8.01 (SEC Filing)
2024-08-26-6.8%newsSeeking AlphaShuttle pharma receives notice of Nasdaq non-compliance
2023-10-30-6.5%legalSEC EDGARSHPH 8-K: 1.01, 8.01 (SEC Filing)
2025-12-29-6.5%legalSEC EDGARSHPH 8-K: 1.01, 3.02 (SEC Filing)
2026-03-12+6.4%newsGlobeNewswireE.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals’ $3.5 Million Public Offering
2024-11-13-6.4%legalSEC EDGARSHPH 8-K: 2.02 and (SEC Filing)
2025-11-26+6.3%legalSEC EDGARSHPH 8-K: 1.01, 2.01, 3.02 (SEC Filing)
2024-10-30+6.1%newsSeeking AlphaShuttle Pharmaceuticals dips 6%, prices $4.5M share offering
2023-05-03-6.1%legalSEC EDGARSHPH 8-K: 5.02 (SEC Filing)
2023-05-03-6.1%newsZacks Investment ResearchShould I buy Shuttle Pharmaceuticals Holdings, Inc. (SHPH) - Zacks Investment Research
2025-04-10-5.8%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2025-10-13-5.8%M&AAI InsiderShuttle Pharma Plans $10 Million Acquisition of AI Startup Molecule.ai to Accelerate Therapeutics Discovery - AI Insider
2024-03-05+5.5%legalSEC EDGARSHPH 8-K: 3.01, 8.01 (SEC Filing)
2022-09-07+5.5%legalSeeking AlphaShuttle Pharmaceuticals stock continues wild post-IPO ride, rallies for second day
2022-09-19-5.3%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2023-05-17-4.7%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2025-06-04+4.7%newsIntellectia AISHPH Forecast — Price Prediction for 2026. Should I Buy SHPH? - Intellectia AI
2023-02-22-4.7%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2024-03-22-4.6%legalSEC EDGARSHPH 8-K: 2.02 and (SEC Filing)
2022-11-20-4.2%newsChartMillSHPH Stock Price, Quote & Chart | SHUTTLE PHARMACEUTICALS HOLD (NASDAQ:SHPH) - ChartMill
2025-07-30-3.9%legalSEC EDGARSHPH 8-K: 5.02 (SEC Filing)
2023-08-03-3.9%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2025-03-31+3.9%legalSEC EDGARSHPH 8-K: 1.01, 5.02 (SEC Filing)
2024-12-19+3.9%legalSEC EDGARSHPH 8-K: 1.01, 8.01 (SEC Filing)
2025-10-09-3.6%newsSeeking AlphaShuttle to enter AI pharmaceutical market
2025-10-09-3.6%newsGlobeNewswireShuttle to Enter $3.24 Billion AI Pharmaceutical Market - GlobeNewswire
2025-10-09-3.6%news富途牛牛Stocks to Watch: Venture Global, Applied Digital, USANA Health Sciences, Shuttle Pharmaceuticals - 富途牛牛
2025-05-28+3.6%legalSEC EDGARSHPH 8-K: 5.02 (SEC Filing)
2025-05-28+3.6%newsThe Business JournalsShuttle Pharmaceuticals slashes exec salaries by 70% as it fights to preserve cash - The Business Journals
2023-11-01+3.6%newsChartMillSHPH Technical Analysis | Trend, Signals & Chart Patterns | SHUTTLE PHARMACEUTICALS HOLD (NASDAQ:SHPH) - ChartMill
2025-06-25-3.4%legalSEC EDGARSHPH 8-K: 1.01, 3.02, 8.01 (SEC Filing)
2025-09-08+3.4%legalSEC EDGARSHPH 8-K: 5.02 (SEC Filing)
2026-02-17-3.4%legalSEC EDGARSHPH 8-K: 2.02 (SEC Filing)
2025-03-25+3.2%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2024-10-25+3.2%legalSEC EDGARSHPH 8-K: 1.01, 3.02 (SEC Filing)
2023-10-10+3.1%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2025-02-26+3.0%newsSeeking AlphaShuttle Pharmaceuticals reports FY results
2025-02-26+3.0%legalSEC EDGARSHPH 8-K: 2.02 and (SEC Filing)
2025-02-26+3.0%executiveStock TitanCan Shuttle Pharma's Glioblastoma Treatment Breakthrough Deliver Returns? CEO Bets $237K - Stock Titan
2024-04-05-3.0%newsSeeking AlphaShuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units
2025-03-12+2.7%executiveSeeking AlphaShuttle Pharmaceuticals appoints Christopher Cooper as interim co-CEO
2025-03-12+2.7%legalSEC EDGARSHPH 8-K: 5.02, 8.01 (SEC Filing)
2024-06-18-2.6%executiveSeeking AlphaShuttle Pharma names Timothy Lorber as CFO
2024-06-18-2.6%legalSEC EDGARSHPH 8-K: 5.02, 8.01 (SEC Filing)
2022-09-10+2.5%earningsMarketBeatShuttle Pharmaceuticals (SHPH) Stock Price, News & Analysis - MarketBeat
2025-01-07-2.5%legalSEC EDGARSHPH 8-K: 3.01, 8.01 (SEC Filing)
2024-08-14+2.5%legalSEC EDGARSHPH 8-K: 1.01, 8.01 (SEC Filing)
2024-04-02+2.4%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2024-02-05-2.4%legalSEC EDGARSHPH 8-K: 1.01, 8.01 (SEC Filing)
2025-05-07-2.2%newsIntellectia AISHPH Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
2025-04-25-2.1%newsStock TitanSHPH Stock Price, News & Analysis - Stock Titan
2023-11-30+1.9%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2023-10-05+1.8%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2023-06-05+1.8%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2025-12-22+1.8%newsintelligentinvestor.com.auShuttle Pharmaceuticals Holdings Inc (NASDAQ:SHPH) - intelligentinvestor.com.au
2025-09-05-1.8%legalSEC EDGARSHPH 8-K: 5.02 (SEC Filing)
2024-09-27-1.7%newsintelligentinvestor.com.auShuttle Pharmaceuticals Holdings Inc (NASDAQ:SHPH) - intelligentinvestor.com.au
2025-11-03-1.7%newsYahoo FinanceShuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00 - Yahoo Finance
2025-11-03-1.7%M&AInvesting.comShuttle Pharma secures $2.5 million in above-market financing deal - Investing.com
2025-02-27+1.6%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2024-09-10-1.5%legalSEC EDGARSHPH 8-K: 1.01 and (SEC Filing)
2023-05-11-1.4%legalSEC EDGARSHPH 8-K: 1.01, 8.01 (SEC Filing)
2025-04-21-1.3%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2024-05-14+1.3%earningsSeeking AlphaShuttle Pharmaceuticals reports Q1 results
2024-05-14+1.3%legalSEC EDGARSHPH 8-K: 2.02 and (SEC Filing)
2024-06-02+1.2%analystZacks Investment ResearchWhat is the current Price Target and Forecast for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) - Zacks Investment Research
2023-09-25+1.1%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2024-02-13+1.0%legalSEC EDGARSHPH 8-K: 1.01, 3.02, 8.01 (SEC Filing)
2022-09-26-1.0%newsTradingViewTechnical Analysis of Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) - TradingView
2023-11-14-0.8%earningsSeeking AlphaShuttle Pharmaceuticals reports Q3 results
2023-11-14-0.8%legalSEC EDGARSHPH 8-K: 2.02 and (SEC Filing)
2024-08-07+0.7%legalSEC EDGARSHPH 8-K: 1.01, 3.03, 5.03, 8.01 (SEC Filing)
2024-04-23-0.6%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2024-10-17-0.4%legalSEC EDGARSHPH 8-K: 1.01, 3.02 (SEC Filing)
2024-09-04+0.3%legalSEC EDGARSHPH 8-K: 8.01 and (SEC Filing)
2024-09-04+0.3%legalGlobeNewswireShuttle Pharma Provides Second Quarter 2024 Corporate Update - GlobeNewswire
2026-03-30-0.1%newsmarketscreener.comShuttle Pharmaceuticals Holdings, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
2026-04-20-0.1%newsStock TitanShuttle Pharma (SHPH) proxy asks investors to OK major reverse split range - Stock Titan
2022-08-31—newsSeeking AlphaShuttle Pharmaceuticals stock soars 373% following $10M IPO (Update)
tickerdossier.comtickerdossier.substack.com